380 results on '"Galli, Aurelio"'
Search Results
2. The dopamine transporter gene SLC6A3: multidisease risks
3. A network of phosphatidylinositol (4,5)-bisphosphate (PIP2) binding sites on the dopamine transporter regulates amphetamine behavior in Drosophila Melanogaster
4. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent
5. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in SLC6A3
6. GLP-1: Molecular mechanisms and outcomes of a complex signaling system
7. Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo
8. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors
9. Amphetamine Induces Dopamine Efflux through a Dopamine Transporter Channel
10. Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter
11. Amphetamine-Induced Loss of Human Dopamine Transporter Activity: An Internalization-Dependent and Cocaine-Sensitive Mechanism
12. Patch-Clamp and Amperometric Recordings from Norepinephrine Transporters: Channel Activity and Voltage-Dependent Uptake
13. Norepinephrine Transporters have Channel Modes of Conduction
14. Bile acid interactions with neurotransmitter transporters
15. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice
16. Impaired mTORC2 signaling in catecholaminergic neurons exaggerates high fat diet-induced hyperphagia
17. Rare Autism-Associated Variants Implicate Syntaxin 1 (STX1 R26Q) Phosphorylation and the Dopamine Transporter (hDAT R51W) in Dopamine Neurotransmission and Behaviors
18. Insights in how amphetamine ROCKs (Rho-associated containing kinase) membrane protein trafficking
19. Novel Method for Monitoring Dopaminergic Activity Ex-vivo in Drosophila melanogaster Using D2-GRAB Sensors
20. Syntaxin 1 Ser 14 phosphorylation is required for nonvesicular dopamine release
21. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function
22. Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward
23. Structural Arrangement of the Intracellular Ca2+ Binding Domains of the Cardiac Na+/Ca2+ Exchanger (NCX1.1): EFFECTS OF Ca2+ BINDING
24. Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4, 5-bisphosphate
25. Role for mTOR Signaling and Neuronal Activity in Morphine-Induced Adaptations in Ventral Tegmental Area Dopamine Neurons
26. Insulin signaling and addiction
27. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD
28. Bile Acids Gate Dopamine Transporter Mediated Currents
29. The dopamine transporter gene SLC6A3: multidisease risks
30. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease
31. Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats
32. Behavioral effects of amphetamine in streptozotocin-treated rats
33. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
34. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease
35. Insulin Replacement Restores the Behavioral Effects of Quinpirole and Raclopride in Streptozotocin-Treated Rats
36. Author response: Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
37. Autism-Associated Variant in the SLC6A3 Gene Alters the Oral Microbiome and Metabolism in a Murine Model
38. Psychomotor Impairments and Therapeutic Implications Revealed by a Mutation Associated with Infantile Parkinsonism-Dystonia
39. Dopamine transport currents are promoted from curiosity to physiology
40. Calmodulin Kinase II Interacts with the Dopamine Transporter C Terminus to Regulate Amphetamine-Induced Reverse Transport
41. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current
42. A dominant-negative variant in the dopamine transporter PDZ-binding motif is linked to parkinsonism and neuropsychiatric disease
43. A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brain
44. Mechanisms of neurotransmitter release by amphetamines: A review
45. Neurotransmitter Transporters
46. Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats
47. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine
48. Amphetamine Regulation of Dopamine Transport: COMBINED MEASUREMENTS OF TRANSPORTER CURRENTS AND TRANSPORTER IMAGING SUPPORT THE ENDOCYTOSIS OF AN ACTIVE CARRIER
49. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine
50. PI 3-kinase regulation of dopamine uptake
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.